Phytotherapy in pediatrics: the production of knowledge and practices in Primary Care

Freire, Cynthia de Jesus; Barbosa, Lucas Roberto da Silva; Costa, João Gomes da; Santos, Renata Guerda de Araújo; Santos, Aldenir Feitosa dos

doi:10.1590/0034-7167-2017-0436

Cited by 11 publications

(11 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Лечение направлено на изменение реологических свой ств секрета и увеличение эффективности кашля. Хорошая сочетаемость препаратов растительного происхождения с другими лекарственными средствами, в т. ч. с антибиотиками, позволяет использовать их не только как средства монотерапии, но и в комбинированной терапии для лечения кашля у детей [16,[24][25][26]. Применение лекарственных средств на основе растительного сырья, особенно для терапии кашля, является очень перспективным вследствие как исторических традиций, так и реально существующей научной базы, доказывающей их эффективность и безопасность.…”

Section: выводыunclassified

The role of herbal medicines in treating cough in children

et al. 2022

View full text Add to dashboard Cite

The physiological role of cough is to restore mucociliary clearance in the respiratory tract. However, if there are inflammatory changes against the background of a respiratory infection, cough may be non-productive and impair the patient’s quality of life. For a rational choice of drug, the true cause of cough should be determined on the basis of history, physical examination and, if necessary, additional instrumental/laboratory investigations. Modern phytopharmaceuticals are considered effective and safe for cough relief. Herbal medicines contain biologically active substances, which are incorporated into the metabolic processes of the body in a more natural way, in contrast to synthetic analogues. The article focuses on the effectiveness of an ivy leaf extract, which has a complex composition: it contains saponins, flavonoids, glycosides, as well as components of essential oils. Due to its composition, it has several effects: expectorant due to its secretolytic and mucolytic action, and antispasmodic based on the increased sensitivity of β2-adrenoreceptor cells of bronchial smooth muscle cells to endogenous and exogenous stimulation, on reducing intracellular calcium levels and bronchial relaxation. The efficacy of ivy leaf extract has been shown in a total of more than 20 clinical trials, mainly in children suffering from upper respiratory tract infections. Cough treatment aims at changing the rheological properties of the secretion and increasing the effectiveness of the cough. The good compatibility of herbal medicines with other drugs, including antibiotics, allows their use not only as monotherapeutic agents, but also in combination therapy for the treatment of cough in children.

show abstract

Section: выводыunclassified

The role of herbal medicines in treating cough in children

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Применение лекарственных растений при симптоматической терапии ОРИ привлекает быстрым облегчением симптоматики, доступностью, положительным отношением ребенка к этим лекарственным формам, эффективно-стью, охотным выбором родителями «природных, натуральных» средств, дешевизной по сравнению со многими другими симптоматическими средствами [9]. Фитотерапия рекомендуется пациентам с небактериальными ОРИ.…”

Section: заключениеunclassified

The herbal preparations in the treatment of cough in children with respiratory infections

Делягин

2019

Med. sov.

View full text Add to dashboard Cite

Acute respiratory infections (ARI, commen cold) are the most common infection diseases in children. They account for up 75% of all cases of respiratory diseases. In most cases, ARI are selfterminating diseases that require only symptomatic treatment. The most common symptom of ARI is cough. In outpatient practice justified the use of herbal medicine. As an antisussive well eastablished syrup Gedelix. The effectivnesses of the medicine, the possibility of accuracy dosing, pleasant taste facilitate it use in children.

show abstract

“…The limitation of conducting clinical trials in paediatric patients is, mainly based on ethical, but also on practical considerations. This results in limited scientific evidence on safety and efficacy for the use of HMPs in children, while there is widespread daily use in clinical practice 2 , 3 , 4 , 5 . In spite of this limitation, in recent years systematic reviews were performed on the use of HMPs by children with obesity 6 , respiratory tract infection 7 , gastrointestinal disorders 8 , 9 and attention deficit hyperactivity disorder (ADHD) 10 .…”

Section: Introductionmentioning

confidence: 99%

Rationalising Optimal Dosing of Phytotherapeutics For Use In Children: Current Status – Potential Solutions – Actions Needed

Hensel,

Bauer,

Heinrich

et al. 2024

Planta Med

View full text Add to dashboard Cite

“Children are not small adults with respect to the treatment with medicinal products”. This statement of WHO was the basis for the initiative of the European Commission for establishment of a paediatric regulation in 2007 to improve health of children by facilitating the development of medicines for children and adolescents. Seventeen years later, in the field of herbal medicinal products results are still sobering. Therefore, the Foundation Plants for Health, Society for Medicinal Plants and Natural Products Research, and German Society for Phytotherapy organized a symposium to assess the status quo for paediatric use of herbal medicinal products (HMPs), to analyse the causes for the current situation, and discuss strategies for establishing the proof of safe and efficacious HMPs for children. Current situation for HMPs and their use in children is not fulfilling requirements of legislation. HMPs in paediatrics are effective and safe, but considering needs of children is necessary. In European countries the use, registration, and marketing of HMPs are different, depending on respective national regulations and specific traditions. EU herbal monographs are the best common denominator for such procedures. Emerging safety discussions must be considered. New approaches by real world data might be a solution. The regulatory framework is to be adapted. Defining rationalized dosing for HMPs can be achieved by extrapolation of data from adults, by using existing clinical data for children, and by using RWD. Therefore a strong need for revising restrictions for use of HMPs in children and rationalizing defined dosage regimes is obvious.

show abstract

Phytotherapy in pediatrics: the production of knowledge and practices in Primary Care

Abstract: Rescuing this tradition brings a new meaning to health care.

Cited by 11 publications

References 14 publications

The role of herbal medicines in treating cough in children

The role of herbal medicines in treating cough in children

The herbal preparations in the treatment of cough in children with respiratory infections

Rationalising Optimal Dosing of Phytotherapeutics For Use In Children: Current Status – Potential Solutions – Actions Needed

Contact Info

Product

Resources

About